Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA)

Overview

Journal J Pers Med

Date 2022 Jun 24

PMID 35743640

Authors

Jae Keun Park

Dongwuk Kim

Jeong Min Lee

Kwang Hyuck Lee

Kyu Taek Lee

Joo Kyung Park

Jong Kyun Lee

Affiliations

Soon will be listed here.

Abstract

Background: The differential diagnosis of immunoglobulin G4-sclerosing cholangitis (IgG4-SC) from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA) is important. In this study, we aimed to find the best combinations of serum IgG subclasses and IgG4 levels for differentiating IgG4-SC from PSC or CCA.

Methods: In total, 31 patients with IgG4-SC, 27 patients with PSC, and 40 patients with CCA were enrolled from 2003 to 2017 at a single tertiary referral center. We retrospectively assessed the IgG4, IgG4/IgG1, IgG4/(IgG1+IgG3), and (IgG4+IgG2)/(IgG1+IgG3) in each of the patients. ROC curves were established to obtain the optimal cutoff value for each parameter. McNemar's test was used to compare the sensitivities, specificities, and accuracies of diagnostic algorithms.

Results: In differentiating IgG4-SC from PSC, the accuracies of IgG4/IgG1 ≥ 0.087 and of IgG4/(IgG1+IgG3) ≥ 0.081 were significantly higher than that of IgG4 ≥ 135 mg/dL alone (78% vs. 66%, = 0.025). Serum IgG4 ≥ 52 mg/dL showed the best accuracy for differentiation of IgG4-SC from CCA, with a sensitivity and specificity of 80% and 82%, respectively, but this was statistically not significant ( = 0.405).

Conclusions: The serum IgG4/IgG1 or IgG4/(IgG1+IgG3) level may help to differentiate IgG4-SC from PSC. IgG4 alone is the most accurate serologic marker for the differentiation of IgG4-SC from CCA.

Citing Articles

The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis.

Vujasinovic M, Said K, Villard C, Carlsson J, Poli C, Maisonneuve P J Clin Med. 2024; 13(1).

PMID: 38202086 PMC: 10779552. DOI: 10.3390/jcm13010079.

Inflammasome and pyroptosis in autoimmune liver diseases.

Wang J, Sun Z, Xie J, Ji W, Cui Y, Ai Z Front Immunol. 2023; 14:1150879.

PMID: 36969233 PMC: 10030845. DOI: 10.3389/fimmu.2023.1150879.

References

Nishino T, Oyama H, Hashimoto E, Toki F, Oi I, Kobayashi M . Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol. 2007; 42(7):550-9. DOI: 10.1007/s00535-007-2038-8. View

Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M . Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010; 78(10):1016-23. DOI: 10.1038/ki.2010.271. View

Chan A, Mudhar H, Shen S, Lang S, Fernando M, Hilmy M . Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment. Br J Ophthalmol. 2017; 101(11):1576-1582. DOI: 10.1136/bjophthalmol-2017-310148. View

Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S . Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005; 30(1):20-5. View

Ghazale A, Chari S, Zhang L, Smyrk T, Takahashi N, Levy M . Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008; 134(3):706-15. DOI: 10.1053/j.gastro.2007.12.009. View

Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M . Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2008; 68(8):1310-5. DOI: 10.1136/ard.2008.089169. View

Mendes F, Jorgensen R, Keach J, Katzmann J, Smyrk T, Donlinger J . Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006; 101(9):2070-5. DOI: 10.1111/j.1572-0241.2006.00772.x. View

Abdul Latiff A, Kerr M . The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007; 44(Pt 2):131-9. DOI: 10.1258/000456307780117993. View

Vosskuhl K, Negm A, Framke T, Weismuller T, Manns M, Wedemeyer H . Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy. Endoscopy. 2011; 44(1):48-52. DOI: 10.1055/s-0030-1256872. View

10.

Oseini A, Chaiteerakij R, Shire A, Ghazale A, Kaiya J, Moser C . Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 2011; 54(3):940-8. PMC: 3253343. DOI: 10.1002/hep.24487. View

11.

Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T . High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344(10):732-8. DOI: 10.1056/NEJM200103083441005. View

12.

Engelhart S, Glynn R, Schur P . Disease associations with isolated elevations of each of the four IgG subclasses. Semin Arthritis Rheum. 2017; 47(2):276-280. DOI: 10.1016/j.semarthrit.2017.03.021. View

13.

Li P, Chen H, Deng C, Wu Z, Lin W, Zeng X . Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related disease in Chinese population. Mod Rheumatol. 2015; 26(4):583-7. DOI: 10.3109/14397595.2015.1117171. View

14.

OReilly D, Malde D, Duncan T, Rao M, Filobbos R . Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol. 2014; 5(2):71-81. PMC: 4025075. DOI: 10.4291/wjgp.v5.i2.71. View

15.

Ang T, Fock K, Ng T, Teo E, Chua T, Tan J . Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol. 2002; 17(8):908-13. DOI: 10.1046/j.1440-1746.2002.02835.x. View

16.

Lee Y, KAPLAN M . Primary sclerosing cholangitis. N Engl J Med. 1995; 332(14):924-33. DOI: 10.1056/NEJM199504063321406. View

17.

Vidarsson G, Dekkers G, Rispens T . IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014; 5:520. PMC: 4202688. DOI: 10.3389/fimmu.2014.00520. View

18.

Nakazawa T, Naitoh I, Hayashi K, Okumura F, Miyabe K, Yoshida M . Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol. 2011; 47(1):79-87. DOI: 10.1007/s00535-011-0465-z. View

19.

Straub B, Esposito I, Gotthardt D, Radeleff B, Antolovic D, Flechtenmacher C . IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch. 2011; 458(6):761-5. DOI: 10.1007/s00428-011-1073-2. View

20.

Bjornsson E, Chari S, Silveira M, Gossard A, Takahashi N, Smyrk T . Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy. Am J Ther. 2010; 18(3):198-205. DOI: 10.1097/MJT.0b013e3181c9dac6. View